Published in Volume
89, Issue 1 (January 1992)
J Clin Invest. 1992;89(1):293–300.
doi:10.1172/JCI115574.
Copyright ©
1992, The American Society for
Clinical Investigation.
Research Article
Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.
E P Jenkins, S Andersson, J Imperato-McGinley, J D Wilson and D W Russell
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas 75235.
Published January 1992
The enzyme steroid 5 alpha-reductase catalyzes the conversion of testosterone into the more potent androgen, dihydrotestosterone, and impairment of this reaction causes a form of male pseudohermaphroditism in which genetic males differentiate predominantly as phenotypic females. We previously isolated cDNA clones that encode a human steroid 5 alpha-reductase enzyme. Here, we report molecular and genetic studies demonstrating that the gene encoding this cDNA is normal in subjects with the genetic disease steroid 5 alpha-reductase deficiency. We further show that in contrast to the major steroid 5 alpha-reductase in the prostate and cultured skin fibroblasts, the cDNA-encoded enzyme exhibits a neutral to basic pH optima and is much less sensitive to inhibition by the 4-aza steroid, finasteride (MK-906). The results provide genetic, biochemical, and pharmacological support for the existence of at least two steroid 5 alpha-reductase isozymes in man.
Browse pages
Click on an image below to see the page. View
PDF of the complete article